Join Our Newsletter
|
Contact
|
Glossary
Facebook
Twitter
Linkedin
MENU
MENU
Latest
The Source Blog
Key Issues
Market Consolidation
Provider Contracts
Price Transparency
Pharmaceuticals
System Reform
COVID-19 Crisis
State Action
SLIHCQ Database
Overview
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
The Source Team
Source Sightings
Latest
The Source Blog
Key Issues
Market Consolidation
Provider Contracts
Price Transparency
Pharmaceuticals
System Reform
COVID-19 Crisis
State Action
Overview
SLIHCQ Database
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
The Source Team
Source Sightings
Search
Articles & Reports
Key Issues
All
HEALTHCARE MARKETS
- Provider Network
-- Telehealth or Telemedicine
-- Scope of Practice
-- Any Willing Provider
-- Network Adequacy
-- Tiered Network or Narrow Network
- Competition
-- Antitrust Enforcement
-- Healthcare Consolidation
-- Most Favored Nation (MFN)
-- Certificate of Need (CON)
-- Certificate of Public Advantage (COPA)
-- Anti-Steering or Anti-Tiering
-- Non-Compete Provision
-- Price Manipulation
-- Competitive Bidding
-- Trade Secret
- Rate Regulation
- ACA Marketplace
HEALTHCARE COSTS
- Cost Containment
-- Shared Savings or Right to Shop
-- Reference Pricing
-- Prior Authorization
-- Utilization Review
- Price Gouging
- Cost-Sharing or Out-of-Pocket Costs
- High Deductible Health Plan (HDHP)
- Health Savings Account (HSA) or Health Reimbursement Account (HRA)
- Benefit Design
- Provider Payment
-- Value-Based Payment
-- Bundled Payment
-- Global Payment or Global Budget
-- Capitation
-- Population-Based Payment
-- Shared Risk or Risk-Based Payment
-- Facility Fee
HEALTHCARE SYSTEM REFORM
- COVID-19 Crisis
- Single Payer or Multi-Payer
- Public Option
- Delivery Reform
- Quality or Value-Based Reform
- Managed Competition
- Accountable Care Organization (ACO)
- Medicaid Reform or Medicaid Waiver
- Affordable Care Act (ACA)
- Federal Reform Effort
PRICE AND QUALITY TRANSPARENCY
- All-Payer Claims Database (APCD)
- Gag Clause or Non-Disclosure Agreement
- Surprise Billing or Balance Billing
- Quality Measure
PHARMACEUTICALS
- Drug Pricing
- Drug Formulary
- Pharmacy Benefit Manager (PBM)
- Pharmacy Regulation
-- Clawback Restriction
- Biosimilar or Generic Competition
-- Generic Competition Block or Delay
- Therapeutic Substitution
- Medicaid Pharmaceuticals
- Medicare Part D
- 340B Drug Pricing Program
- Drug Importation
Jurisdiction
All
Federal
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Start Date
End Date
Kaiser Family Foundation
Insurer Participation on the ACA Marketplaces, 2014-2021
November 23, 2020
The Commonwealth Fund
State Trends in Employer Premiums and Deductibles, 2010–2019
November 20, 2020
Health Affairs
Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic
November 19, 2020
Council for Informed Drug Spending Analysis
High Drug Prices: Costing Millions of Lives and Billions of Dollars
November 18, 2020
The Commonwealth Fund
The Benefits and Limitations of State-Run Individual Market Reinsurance
November 11, 2020
Urban Institute
ACA Offers Protection as the COVID-19 Pandemic Erodes Employer Health Insurance Coverage
November 9, 2020
American Antitrust Institute
What Does Expanding Horizontal Control Mean for Antitrust Enforcement? A Look at Mergers, Partial Ownership, and Joint Ventures
November 4, 2020
Kaiser Family Foundation
How costly are common health services in the United States?
November 4, 2020
The Center for Connected Health Policy
State Telehealth Laws and Reimbursement Policies
November 4, 2020
Health Affairs
Getting The Price Right: How Some Countries Control Spending In A Fee-For-Service System
November 2, 2020
NEJM
Implications of the 2020 Election for U.S. Health Policy
October 29, 2020
American Medical Association
Competition in Health Insurance: A comprehensive study of U.S. markets
October 14, 2020
Annals of Internal Medicine
Surprise Billing for Colonoscopy: The Scope of the Problem
October 13, 2020
Kaiser Family Foundation
Health Insurer Financial Performance Amid the Coronavirus Pandemic
October 12, 2020
NASHP
Understanding the Health Care Cost Conundrum in 2020
October 12, 2020
Kaiser Family Foundation
A Reconfigured U.S. Supreme Court: Implications for Health Policy
October 9, 2020
Next
